Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Chimeric Antigen Receptor T Cells Combined With Eps8 Peptide Specific Dendritic Cell for Patients With Relapsed/Refractory Leukemia and Myelodysplastic Syndromes

NCT03291444 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT03291444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03291444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Chimeric Antigen Receptor T Cells Combined With Eps8 Peptide Specific Dendritic Cell for Patients With Relapsed/Refractory Leukemia and Myelodysplastic Syndromes
Lead sponsor
Zhujiang Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
May 5, 2018
Completion date
June 1, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute lymphocytic (all), leukemia, acute myelogenous (aml), myelodysplastic syndromes